Newsroom

A blog post published by DiabetesMine explores why many hospitals still use an old-fashioned, time-consuming, error-prone approach to glucose management versus a technology-enabled approach like EndoTool, noting a big challenge is convincing hospital administration and providers this should be a priority.

The company will be hosting its annual EndoTool User Group Meeting on October 18th at the Ballantyne Hotel in Charlotte, NC.

The U.S. Patent and Trademark Office (USPTO) has issued a new patent allowance, “Systems and Methods for Determining Insulin Therapy for a Patient,” describing unique methods and systems for more individualized insulin therapy in the inpatient setting.

Drs. Carlos Mendez and Brian Ulmer join a roster of medical experts to support the company in delivering individualized insulin dosing for improved inpatient diabetes management.

Providers can bridge the gap between inpatient and outpatient glycemic management with Monarch’s EndoTool® Glucose Management System and Voluntis’ Insulia®

The company, a leader in precision insulin dosing for optimized inpatient glucose management, has been selected by Modern Healthcare as one of the 2018 Best Places to Work in Healthcare.

Presenter Jane Jeffrie Seley, Program Manager of Inpatient Glycemic Control Program at NewYork-Presbyterian Hospital/Weill Cornell Medicine, will focus on strategies to engage nursing staff in glycemic management practices.

An article published by ACP Hospitalist explores how recommended glucose targets remain elusive for many hospitals, but some have made inroads by leveraging the power of computerized systems to optimize insulin dosing.

An article in Becker’s Health IT & CIO Review explores why hospital medical errors continue to remain one of the leading causes of death in the United States, and how adoption of new technologies, such as an electronic glucose management system for insulin dosing, can go a long way toward improving patient safety.

The new module enables clients to further mine patient data and identify larger trends in clinical outcomes and processes using existing analytics tools and infrastructure.

The company will host a complimentary webinar, “Beyond Sliding Scale: Closing the Gap Between Current and Optimal Glycemic Management Practices.”

The company will be hosting the first annual EndoTool User Group Meeting on October 19th at the Hotel Le Méridien in Charlotte, NC.

Fuqua will lead the overall clinical vision, providing input into product strategy and working closely with customers on adoption and optimization of the EndoTool® platform.

An article published by Diabetes Times explores a seven-year study on the use of a computer-guided glucose management system (EndoTool) and its impact on various quality metrics, such as hyperglycemia, hypoglycemia and time to control.

An article published by Endocrine Today explores a seven-year study on the use of a computer-guided glucose management system (EndoTool) and its impact on various quality metrics, such as hyperglycemia, hypoglycemia and time to control.